# Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION

Study · id `cardio:ct-nct07388030` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07388030](<https://clinicaltrials.gov/study/NCT07388030>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07388030

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3060 participants.

## Technical summary

Registry record NCT07388030. Randomized; single masking; primary purpose treatment. Start 2026-03-20 (anticipated); primary completion 2030-01-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3060 participants (planned count; ClinicalTrials.gov record NCT07388030, source copy `cardio:ctgov-nct07388030-2026-03-12`, retrieved 2026-10-26)
- Planned start: 2026-03-20 (anticipated) (ClinicalTrials.gov record NCT07388030, source copy `cardio:ctgov-nct07388030-2026-03-12`, retrieved 2026-10-26)
- Primary completion: 2030-01-20 (anticipated) (ClinicalTrials.gov record NCT07388030, source copy `cardio:ctgov-nct07388030-2026-03-12`, retrieved 2026-10-26)
- Completion: 2030-06-30 (anticipated) (ClinicalTrials.gov record NCT07388030, source copy `cardio:ctgov-nct07388030-2026-03-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07388030, source copy `cardio:ctgov-nct07388030-2026-03-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07388030-2026-03-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION
- Acronym: LOCATION
- Condition: Coronary Artery Disease
- Condition: Severe Coronary Artery Disease
- Condition: Coronary Artery Calcification
- Intervention (Device): IVL Pretreatment + OCT-Guided Stent Implantation
- Intervention (Device): IVL Pretreatment + Angiography-Guided Stent Implantation
- Intervention (Device): Balloon Angioplasty (BA) Pretreatment + OCT-Guided Stent Implantation
- Intervention (Device): Balloon Angioplasty (BA) Pretreatment + Angiography-Guided Stent Implantation
- Lead sponsor: Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shanghai Bluesail Boyuan Medical Technology Co., Ltd. (`cardio:org-shanghai-bluesail-boyuan-medical-technology-co-ltd`)

## Provenance

Content hash: 609fe96d019447794fe05d52458c6944dd5149dccfea7c764897b839fdd8d7f0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
